Mitsubishi Chemical Group Misses Profit Forecast After Impairments, Executives Cut Pay

An update from Mitsubishi Chemical Holdings ( (JP:4188) ) is now available.

Mitsubishi Chemical Group reported that sales for the year ended March 31, 2026 slightly exceeded its earlier forecast, but core operating income and net profit fell well short after sizable impairment losses. The write-downs related to Soarnol production facilities in the Specialty Materials segment and ethylene oxide and ethylene glycols plants in the Basic Materials & Polymers segment sharply reduced earnings versus guidance, even as industrial gases remained a profit driver.

The weaker results underscore ongoing restructuring pressures following the transfer of its pharmaceutical subsidiary and highlight profitability challenges in certain materials lines. In response to the impairment at Soarnol, the company’s president and CEO and the executive in charge of the affected business at Mitsubishi Chemical Corporation will voluntarily return 20% of their monthly compensation for six months, signaling accountability to investors and other stakeholders.

The most recent analyst rating on (JP:4188) stock is a Hold with a Yen900.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.

More about Mitsubishi Chemical Holdings

Mitsubishi Chemical Group Corporation is a diversified Japanese chemical manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The group operates across specialty materials, basic materials and polymers, industrial gases and related businesses, supplying key inputs to global manufacturing, healthcare and industrial customers while reshaping its portfolio through asset transfers and structural reforms.

Average Trading Volume: 7,484,574

Technical Sentiment Signal: Buy

Current Market Cap: Yen1220.6B

Find detailed analytics on 4188 stock on TipRanks’ Stock Analysis page.